Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 964070, 13 pages
http://dx.doi.org/10.1155/2013/964070
Research Article

Resveratrol Is Not as Effective as Physical Exercise for Improving Reproductive and Metabolic Functions in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome

1Department of Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Box 434, 405 30 Gothenburg, Sweden
2Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China
3Department of Reproductive Medicine, School of Medicine, University of California, San Diego, CA 92103, USA
4Department of Integrative Medicine and Neurobiology, State Key Lab of Medical Neurobiology, Shanghai Medical College, Institute of Acupuncture Research, Institutes of Brain Science, Fudan University, Shanghai 20032, China
5Department of Internal Medicine, Institute of Medicine, Centre for Bone and Arthritis Research, The Sahlgrenska Academy at the University of Gothenburg, 40530 Gothenburg, Sweden

Received 13 January 2013; Accepted 4 March 2013

Academic Editor: Andreas Sandner-Kiesling

Copyright © 2013 Anna Benrick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gilling-Smith, D. S. Willis, R. W. Beard, and S. Franks, “Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 4, pp. 1158–1165, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Gambineri, L. Patton, A. Vaccina et al., “Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3970–3980, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. B. Sverrisdóttir, T. Mogren, J. Kataoka, P. O. Janson, and E. Stener-Victorin, “Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?” American Journal of Physiology, vol. 294, no. 3, pp. E576–E581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Faulds, M. Rydén, I. Ek, H. Wahrenberg, and P. Arner, “Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2269–2273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Mannerås-Holm, H. Leonhardt, J. Kullberg et al., “Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. E304–E311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Skov, D. Glintborg, S. Knudsen et al., “Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome,” Diabetes, vol. 56, no. 9, pp. 2349–2355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Covington, E. Ravussin, and L. M. Redman, “Reduced expression of SIRT1 and SIRT3 in the skeletal muscle of PCOS women,” in The Endocrine Society's 95th Annual Meeting and Expo (ENDO '12), San Francisco, Calif, USA, June 2013.
  8. L. Mannerås, S. Cajander, A. Holmäng et al., “A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome,” Endocrinology, vol. 148, no. 8, pp. 3781–3791, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Mannerås, S. Cajander, M. Lönn, and E. Stener-Victorin, “Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS,” American Journal of Physiology, vol. 296, no. 4, pp. R1124–R1131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Jedel, F. Labrie, A. Odén et al., “Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial,” American Journal of Physiology, vol. 300, no. 1, pp. E37–E45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Feng, J. Johansson, R. Shao, L. Manneras-Holm, H. Billig, and E. Stener-Victorin, “Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5alpha-dihydrotestosterone-induced rat polycystic ovary syndrome model,” Experimental Physiology, vol. 97, pp. 651–662, 2012. View at Google Scholar
  12. H. Jiang, L. Zhang, J. Kuo et al., “Resveratrol-induced apoptotic death in human U251 glioma cells,” Molecular Cancer Therapeutics, vol. 4, pp. 554–561, 2005. View at Google Scholar
  13. K. Szkudelska and T. Szkudelski, “Resveratrol, obesity and diabetes,” European Journal of Pharmacology, vol. 635, no. 1–3, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Ortega, J. A. Villanueva, D. H. Wong et al., “Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway,” Endocrinology, vol. 153, pp. 4019–4029, 2012. View at Google Scholar
  15. D. H. Wong, J. A. Villanueva, A. B. Cress, and A. J. Duleba, “Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells,” Molecular Human Reproduction, vol. 16, no. 4, pp. 251–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Borra, B. C. Smith, and J. M. Denu, “Mechanism of human SIRT1 activation by resveratrol,” Journal of Biological Chemistry, vol. 280, no. 17, pp. 17187–17195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Sang, J. C. Il, and G. K. Sang, “Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3β inhibition downstream of poly(ADP-ribose) polymerase-LKB1 pathway,” Molecular Pharmacology, vol. 76, no. 4, pp. 884–895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Park, F. Ahmad, A. Philp et al., “Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases,” Cell, vol. 148, pp. 421–433, 2012. View at Google Scholar
  19. P. J. Fernandez-Marcos and J. Auwerx, “Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis,” American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 884S–890S, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Cantó and J. Auwerx, “PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure,” Current Opinion in Lipidology, vol. 20, no. 2, pp. 98–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Hawley and S. J. Lessard, “Exercise training-induced improvements in insulin action,” Acta Physiologica, vol. 192, no. 1, pp. 127–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. M. Hoeger, “Exercise therapy in polycystic ovary syndrome,” Seminars in Reproductive Medicine, vol. 26, no. 1, pp. 93–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Das, H. S. Lin, P. C. Ho, and K. Y. Ng, “The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol,” Pharmaceutical Research, vol. 25, no. 11, pp. 2593–2600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. F. K. Marcondes, F. J. Bianchi, and A. P. Tanno, “Determination of the estrous cycle phases of rats: some helpful considerations,” Brazilian Journal of Biology, vol. 62, no. 4, pp. 609–614, 2002. View at Google Scholar · View at Scopus
  25. T. Björnheden, B. Jakubowicz, M. Levin et al., “Computerized determination of adipocyte size,” Obesity Research, vol. 12, no. 1, pp. 95–105, 2004. View at Google Scholar · View at Scopus
  26. I. Ortega, A. B. Cress, D. H. Wong et al., “Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells,” Biology of Reproduction, vol. 86, pp. 1–9, 2012. View at Google Scholar
  27. J. A. Baur, K. J. Pearson, N. L. Price et al., “Resveratrol improves health and survival of mice on a high-calorie diet,” Nature, vol. 444, no. 7117, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Rivera, R. Morón, A. Zarzuelo, and M. Galisteo, “Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats,” Biochemical Pharmacology, vol. 77, no. 6, pp. 1053–1063, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Palsamy and S. Subramanian, “Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats,” Journal of Cellular Physiology, vol. 224, no. 2, pp. 423–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Kim, Y. Jin, Y. Choi, and T. Park, “Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice,” Biochemical Pharmacology, vol. 81, no. 11, pp. 1343–1351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. L. Chen, H. H. Zhang, J. Zheng et al., “Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial beta-oxidation,” Metabolism, vol. 60, pp. 1598–1609, 2011. View at Google Scholar
  32. C. Saraceni and T. L. Broderick, “Cardiac and metabolic consequences of aerobic exercise training in experimental diabetes,” Current Diabetes Reviews, vol. 3, no. 1, pp. 75–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. L. Bradley, J. Y. Jeon, F. F. Liu, and E. Maratos-Flier, “Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice,” American Journal of Physiology, vol. 295, no. 3, pp. E586–E594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Mannerås, I. H. Jonsdottir, A. Holmäng, M. Lönn, and E. Stener-Victorin, “Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome,” Endocrinology, vol. 149, no. 7, pp. 3559–3568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Yoshino, C. Conte, L. Fontana et al., “Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance,” Cell Metabolism, vol. 16, no. 5, pp. 658–664, 2012. View at Publisher · View at Google Scholar
  36. W. Kang, H. J. Hong, J. Guan et al., “Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents,” Metabolism, vol. 61, pp. 424–433, 2012. View at Google Scholar
  37. C. L. Harrison, C. B. Lombard, L. J. Moran, and H. J. Teede, “Exercise therapy in polycystic ovary syndrome: a systematic review,” Human Reproduction Update, vol. 17, no. 2, pp. 171–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. You, K. M. Murphy, M. F. Lyles, J. L. Demons, L. Lenchik, and B. J. Nicklas, “Addition of aerobic exercise to dietary weight loss preferentially reduces abdominal adipocyte size,” International Journal of Obesity, vol. 30, no. 8, pp. 1211–1216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Alberdi, V. M. Rodriguez, J. Miranda et al., “Changes in white adipose tissue metabolism induced by resveratrol in rats,” Nutrition & Metabolism, vol. 8, p. 29, 2011. View at Google Scholar
  40. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alphaα,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Lasa, M. Schweiger, P. Kotzbeck et al., “Resveratrol regulates lipolysis via adipose triglyceride lipase,” Journal of Nutritional Biochemistry, vol. 23, pp. 379–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Baile, J. Y. Yang, S. Rayalam et al., “Effect of resveratrol on fat mobilization,” Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 40–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. T. Macarulla, G. Alberdi, S. Gómez et al., “Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet,” Journal of Physiology and Biochemistry, vol. 65, no. 4, pp. 369–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Deblois and V. Giguère, “Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease,” Biochimica et Biophysica Acta, vol. 1812, no. 8, pp. 1032–1040, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Gao, L. H. Wei, P. M. Sun et al., “Regulation of orphan receptor ERRα by estrogen and progesterone in endometrial carcinoma cell line,” Journal of Peking University. Health Sciences, vol. 37, no. 3, pp. 281–283, 2005. View at Google Scholar · View at Scopus
  46. M. Nilsson, C. Ohlsson, D. Mellstrom, and M. Lorentzon, “Sport-specific association between exercise loading and the density, geometry, and microstructure of weight-bearing bone in young adult men,” Osteoporosis International, 2012. View at Publisher · View at Google Scholar
  47. E. I. Barengolts, P. V. Lathon, D. J. Curry, and S. C. Kukreja, “Effects of endurance exercise on bone histomorphometric parameters in intact and ovariectomized rats,” Bone and Mineral, vol. 26, no. 2, pp. 133–140, 1994. View at Google Scholar · View at Scopus
  48. V. R. Yingling, S. Davies, and M. J. Silva, “The effects of repetitive physiologic loading on bone turnover and mechanical properties in adult female and male rats,” Calcified Tissue International, vol. 68, no. 4, pp. 235–239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Boissy, T. L. Andersen, B. M. Abdallah, M. Kassem, T. Plesner, and J. M. Delaissé, “Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation,” Cancer Research, vol. 65, no. 21, pp. 9943–9952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Rayalam, M. A. Della-Fera, and C. A. Baile, “Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis,” Molecular Nutrition and Food Research, vol. 55, no. 8, pp. 1177–1185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. J. L. Su, C. Y. Yang, M. Zhao, M. L. Kuo, and M. L. Yen, “Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol,” Journal of Biological Chemistry, vol. 282, no. 27, pp. 19385–19398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. P. Liu, W. X. Li, B. Yu et al., “Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model,” Journal of Medicinal Food, vol. 8, no. 1, pp. 14–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. K. J. Pearson, J. A. Baur, K. N. Lewis et al., “Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span,” Cell Metabolism, vol. 8, no. 2, pp. 157–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Stener-Victorin, E. Jedel, P. O. Janson, and Y. B. Sverrisdottir, “Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome,” American Journal of Physiology, vol. 297, no. 2, pp. R387–R395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. P. S. Duggal, K. H. Van Der Hoek, C. R. Milner et al., “The in vivo and in vitro effects of exogenous leptin on ovulation in the rat,” Endocrinology, vol. 141, no. 6, pp. 1971–1976, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. V. W. Dolinsky, C. F. Rueda-Clausen, J. S. Morton, S. T. Davidge, and J. R. Dyck, “Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted,” Diabetes, vol. 60, pp. 2274–2284, 2011. View at Google Scholar
  57. L. Biasutto, E. Marotta, S. Garbisa, M. Zoratti, and C. Paradisi, “Determination of quercetin and resveratrol in whole blood-implications for bioavailability studies,” Molecules, vol. 15, no. 9, pp. 6570–6579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. E. Juan, M. Maijó, and J. M. Planas, “Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 2, pp. 391–398, 2010. View at Publisher · View at Google Scholar · View at Scopus